Byron Robinson - Chief Strategy Officer at Janux Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Strategy Officer
Stock Symbol
JANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Byron Robinson since 12/5/2024

Holdings reported by Byron Robinson for Janux Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 28K $1.61M $57.37 Jan 2, 2025 Direct
Stock option (right to buy) 98K Jan 2, 2025 Direct Common Stock

Transactions reported by Byron Robinson for Janux Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.